BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS

Overview Fund Activity
Delisted

BIOS was delisted on the 6th of October, 2023.

Back to rankings

30 hedge funds and large institutions have $135M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 6 closing their positions.

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAC
1
Cowen and Company
New York
$7.36M
2
WRBC
2
W.R. Berkley Corp
Connecticut
$12.1M
3
BCM
3
BCK Capital Management
Connecticut
$805K
4
WAM
4
Wolverine Asset Management
Illinois
$5.65M
5
VF
5
Virtu Financial
New York
$221K

Top Sellers

1
QL
1
Quarry LP
New York
$0
2
MSU
2
Mizuho Securities USA
New York
$7.27M
3
SFM
3
Spartan Fund Management
Canada
$0
4
PCM
4
Prelude Capital Management
New York
$0
5
OCM
5
Oaktree Capital Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ETH
26
Exos TFP Holdings
New York
$650K – – –
AMC
27
Atlas Merchant Capital
New York
$542K – – –
VF
28
Virtu Financial
New York
$221K +$221K +20,445 New
KIM
29
Karpus Investment Management
New York
$111K – – –
CS
30
Clear Street
New York
$11 +$11 +1 New
QL
31
Quarry LP
New York
– -$4.85M -455,000 Closed
SFM
32
Spartan Fund Management
Canada
– -$3.41M -270,578 Closed
PCM
33
Prelude Capital Management
New York
– -$1.6M -150,000 Closed
OCM
34
Oaktree Capital Management
California
– -$1.07M -100,000 Closed
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
– -$753K -68,435 Closed
UBS Group
36
UBS Group
Switzerland
– -$19.5K -1,828 Closed
1
2